Sleep Promotion for Teen Hypertension

This study is looking at a new way to help teenagers (ages 13-18) with high blood pressure (hypertension) get more sleep. The study will test a program that encourages parent-child pairs to meet a sleep goal. This program uses text messages with sleep tips and a virtual account where money is deducted if sleep goals aren't met. Researchers want to see if this approach can increase how long teens sleep and lower their blood pressure. To join, you should speak English, have internet access or a smartphone, and typically sleep 7.5 hours or less on school nights. The study is currently unclear on its recruitment status.

Study design
This is a home-based study involving 10 participants (5 parent-child pairs). It is an interventional study, meaning participants will receive a specific intervention.
What's involved
During a 7-week intervention, you and your child will receive sleep guidance text messages and weekly performance updates. You will also use a sleep tracker throughout the study, which lasts about 11 weeks.
Compensation
Not stated in the trial record.
Follow-up
Your blood pressure and sleep duration will be measured from the start of the study until approximately week 11.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06642246

Sleep Promotion and Pediatric Hypertension

Recruiting
NAAges 13–18Interventional
Children's Hospital of Philadelphia
~10 participants
Updated 2026-08-28 on ClinicalTrials.gov
What's tested:Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hypertension
Measured over From baseline to approximately week 11
+1 more outcome measured
Insufficient Sleep
Hypertension
1 sites across 1 states
Pennsylvania1
  • Jonathan Mitchell, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital of Philadelphia

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Speak, read and write in English.
Parental/guardian permission (informed consent) and child assent.
Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan.
Parent reported sleep duration on school nights less than or equal to 7.5 hours.
Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM).
If taking over the counter sleep aides, willing to stop them over the course of the study.
Be the parent/guardian of an eligible child enrolled in the main study.
Speak, read, and write in English.

Exclusion

Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide.
Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes).
  • HypertensionFrom baseline to approximately week 11

    The number of participants who are still diagnosed with hypertension by ambulatory blood pressure monitoring (ABPM). This is defined as a mean systolic or diastolic blood pressure when either awake or asleep, greater than the 95th percentile.

  • Change in sleep tracker estimated weeknight sleep durationFrom baseline to approximately week 11

    Change in sleep tracker estimated weeknight sleep duration will be measured from baseline (operationalized as the average hours per weeknight per week). There will be one week of baseline data and seven weeks of intervention data as well as two weeks of follow-up data.